Quality · Access · Hope
Countries

🇭🇰 Country Profile

Hong Kong

Medicine from India reaching Hong Kong

🇭🇰 $47.0M
All data from DGCIS India export records (fiscal year, April–March).
$47.0M
Scale
India supplies $47.0M in pharmaceutical products to Hong Kong — affordable medicine reaching Asia-Pacific.
73%
Medicine
Primarily medicines (73%), supplemented by medicine ingredients and surgical & hospital supplies.
1.2×
Trajectory
Steady growth over the decade: India's pharmaceutical supply to Hong Kong has expanded 1.2×.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Affordable, quality pharmaceutical products from India — part of a global supply network reaching patients in 200+ countries.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $34.4M (72.9%) Medicine Ingredients $9.6M (20.4%) Surgical & Hospital Supplies $1.6M (3.5%) Traditional & Herbal $1.2M (2.5%) Vaccines $0.30M (0.6%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Hong Kong Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Hong Kong: $25.1M across 3 filings (2011-2019).